Article Information
History
- April 18, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Giovanna Barbosa Correia Rielloa,b,
- Priscila Mendonça da Silvac,
- Francisca Andrea da Silva Oliveirab,
- Roberta Taiane Germano de Oliveirac,
- Francisco Eliclecio Rodrigues da Silvad,
- Ivo Gabriel da Frota Françac,
- Fábio Miyajimag,
- Vânia Maria Maciel Meloe,
- Ronald Feitosa Pinheiroc,# and
- Danielle S. Macedod,f,#,*
- aDepartment of Clinical and Toxicological Analysis, School of Pharmacy, Federal University of Ceara, Fortaleza, CE, Brazil
- bDrug research and Development Center, Faculty of Medicine, Federal University of Ceara, Brazil
- cCancer Cytogenomic Laboratory, Drug Research, and Development Center, Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceara, Fortaleza, Brazil
- dLaboratory of Neuropsychopharmacology, Drug Research and Development Center, Faculty of Medicine, Federal University of Ceara, Fortaleza, CE, Brazil
- eLaboratory of Microbial Ecology and Biotechnology, Biology Department, Federal University of Ceará, Fortaleza, Brazil
- fNational Institute for Translational Medicine (INCT-TM, CNPq), Ribeirão Preto, SP
- gOswaldo Cruz Foundation (Fiocruz), Branch Ceara, Eusebio, Brazil
- ↵*Corresponding Author:
Danielle S. Macedo. Drug Research and Development Center. Rua Coronel Nunes de Melo 1000. Rodolfo Teófilo. Fortaleza, Ceará, Brazil. Zip code: 60430-271. Danielle.macedo{at}ufc.br; daniellesilmacedo{at}gmail.com
↵# Both must be considered as seniors co-authors.
Posted April 18, 2022.
Gut microbiota composition correlates with disease severity in myelodysplastic syndrome
